home / stock / atxi / atxi quote
Last: | $2.87 |
---|---|
Change Percent: | -7.02% |
Open: | $3.81 |
Close: | $2.87 |
High: | $3.9313 |
Low: | $2.79 |
Volume: | 773,060 |
Last Trade Date Time: | 07/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.87 | $3.81 | $2.87 | $3.9313 | $2.79 | 773,060 | 07-25-2024 |
$3.56 | $3.54 | $3.56 | $3.74 | $3.5 | 188,740 | 07-24-2024 |
$3.64 | $3.495 | $3.64 | $3.65 | $3.4 | 117,091 | 07-23-2024 |
$3.45 | $3.5 | $3.45 | $3.5 | $3.32 | 12,121 | 07-22-2024 |
$3.45 | $3.49 | $3.45 | $3.6299 | $3.45 | 15,760 | 07-19-2024 |
$3.4251 | $3.43 | $3.4251 | $3.6906 | $3.3701 | 14,856 | 07-18-2024 |
$3.5316 | $3.57 | $3.5316 | $3.61 | $3.45 | 11,931 | 07-17-2024 |
$3.61 | $3.49 | $3.61 | $3.76 | $3.3828 | 114,282 | 07-16-2024 |
$3.49 | $3.5 | $3.49 | $3.5897 | $3.3501 | 35,590 | 07-15-2024 |
$3.48 | $3.5502 | $3.48 | $3.59 | $3.46 | 11,567 | 07-12-2024 |
$3.5 | $3.48 | $3.5 | $3.6 | $3.35 | 31,699 | 07-11-2024 |
$3.44 | $3.58 | $3.44 | $3.58 | $3.4086 | 9,336 | 07-10-2024 |
$3.4228 | $3.46 | $3.4228 | $3.573 | $3.33 | 39,681 | 07-09-2024 |
$3.4147 | $3.4 | $3.4147 | $3.6399 | $3.31 | 79,058 | 07-08-2024 |
$3.345 | $3.39 | $3.345 | $3.4599 | $3.21 | 15,422 | 07-05-2024 |
$3.41 | $3.43 | $3.41 | $3.46 | $3.255 | 15,313 | 07-04-2024 |
$3.41 | $3.43 | $3.41 | $3.46 | $3.255 | 15,313 | 07-03-2024 |
$3.41 | $3.5262 | $3.41 | $3.5262 | $3.34 | 15,582 | 07-02-2024 |
$3.4 | $3.57 | $3.4 | $3.5899 | $3.4 | 22,247 | 07-01-2024 |
$3.5 | $3.65 | $3.5 | $3.79 | $3.5 | 49,885 | 06-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Avenue Therapeutics Inc. Company Name:
ATXI Stock Symbol:
NASDAQ Market:
Avenue Therapeutics Inc. Website:
MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced tha...
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the ...
– Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – MIAMI, May 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutica...